Immunotherapy for Recurrent Glioma—From Bench to Bedside

SIMPLE SUMMARY: Glioma is the most common and aggressive brain tumor worldwide, and most patients suffer from a recurrence. Additionally, recurrent glioma is often resistant to chemotherapies and radiotherapy. Hence, immunotherapy has come into people’s sights. The most-used immunotherapy is immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Yi, Zhou, Guanyu, Zhao, Kejia, Chen, Yaohui, Shen, Shensi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340154/
https://www.ncbi.nlm.nih.gov/pubmed/37444531
http://dx.doi.org/10.3390/cancers15133421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340154/
https://www.ncbi.nlm.nih.gov/pubmed/37444531
http://dx.doi.org/10.3390/cancers15133421

Ejemplares similares